<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="https://imcjms.com/assets/rss.css" ?><rss version="2.0">
<channel>
    <title>IMC Journal of Medical Science</title>
    <link>https://imcjms.com</link>
    <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                <title><![CDATA[Clinically
significant minor blood group antigens amongst South Indian donor population]]></title>

                                    <author><![CDATA[Soonam John]]></author>
                                    <author><![CDATA[Archana Kuruvanplackal Achankunju]]></author>
                                    <author><![CDATA[Madathingal Sugathan Suma]]></author>
                                    <author><![CDATA[Sasikala Nadanganan]]></author>
                
                <link data-url="https://imcjms.com/registration/journal_full_text/484">
    https://imcjms.com/registration/journal_full_text/484
</link>
                <pubDate>Tue, 12 Sep 2023 10:03:24 +0000</pubDate>
                <category><![CDATA[Original Article]]></category>
                <comments><![CDATA[IMC J Med Sci. 2024; 18(1):004]]></comments>
                <description>Abstract
Background and
objectives: Distribution of blood group antigen varies
among different races. It is important to know the distribution of these
antigens so as to provide a donor database that aid in providing compatible
blood units for patients with multiple alloantibodies. The present study was
conducted to determine the distribution of clinically significant minor blood
group antigens amongst the South Indian blood donors.
&amp;nbsp;Materials
and methods: Blood samples were collected from
healthy regular repeat voluntary blood donors of same ethnicity attending a
tertiary care hospital in South Kerala. Clinically significant blood antigens
of the ABO, Rh (D, C, c, E, and e), Kell, Duffy and Kidd blood group systems
were determined. The ABO and Rh(D) grouping were performed by tube technique
using monoclonal antisera. Column agglutination technique was used to phenotype
Rh, Kell, Duffy and Kidd antigens.
Results:
Total 200 healthy repeat voluntary blood donors were enrolled in the study. Out
of 200 donors, 92% were RhD positive. Among the Rh antigens, the e antigen was
positive in 97.8 % and 100% among the Rh(D) positive and Rh(D) negative donors
respectively. No E antigen was detected in RhD negative donors. Total 6 and 2
Rh phenotypes were observed among the Rh(D) positive and negative donors
respectively. R1R1 and Rr were the most frequent phenotypes among the RhD
positive and negative donors (47.28% and 93.75%) respectively. Among the Kell
blood group antigens, K and Kpb antigens were present in 100% of our
donors while in Duffy and Kidd system Fya and Jka
were most predominant (89% and 87%) respectively. 
Conclusions:
The findings of the present study would be helpful in developing in-house panel
cells. Moreover, a rare donor registry of donors typed negative for a
high-frequency antigen can be formulated.
IMC J Med Sci. 2024; 18(1):004.
DOI: https://doi.org/10.55010/imcjms.18.004
*Correspondence: Soonam John, Department of Transfusion Medicine, Government Medical
College, Parippally, Kollam, Kerala,India. Email: johnsoonam@gmail.com
&amp;nbsp;
Introduction

The blood transfusion requirement for the
treatment of haemoglobinopathies in India is on an increase at a rate of 30
units per patient annually [1]. These chronically transfused patients develop
clinically significant antibodies which can result in hemolytic transfusion
reactions and haemolytic disease of fetus and newborn. The traditional practice
is to provide antigen-negative blood when an antibody against a blood group
system has been formed [2]. In these patients it is really tedious to find a
compatible unit, especially if multiple antibodies have been formed in the
patient. The situation can be worsened if an emergency transfusion is required.
There are currently 44 recognised blood group
systems containing 354 red cell antigens [3]. There exists racial and ethnic
differences in blood group antigen distributions [4-7]. There is very little information
available regarding distribution of various clinically significant minor blood
group antigens in South India. The present study was conducted to determine the
frequency of clinically significant minor blood group antigens - Rh (C, c, E
and e), Kell (K, k, Kpa and Kpb), Kidd (Jka and Jkb), Duffy (Fya and Fyb) amongst
regular voluntary blood donors and to form a donor database on red blood cell (RBC)
antigens in the South Indian population. 
&amp;nbsp;
Materials
and methods
This prospective descriptive study was
conducted in the Model Blood Bank, Department of Transfusion Medicine, Government
Medical College, Thiruvananthapuram, after approval by the Institutional
Research and Ethics Committee. The hospital is a major tertiary care hospital
in South Kerala, with super speciality, emergency, and surgical services. 
Blood samples were collected from healthy repeat
voluntary blood donors between September 2018 and August 2019. Blood donors
were selected from the state of Kerala (a state in South India) while donors
who were from the other Indian states and foreign citizens were excluded so as
to incorporate study participants with same ethnicity. The donors were selected
as per the criteria laid down by the Drugs and Cosmetics Act, 1940 and Rules,
1945 and departmental Standard Operating Procedures (SOP). Written informed
consent was obtained from each donor at the time of donor counselling and
screening. About 2ml of blood sample was collected from each donor in sample
tubes containing ethylenediaminetetraacetic acid (EDTA) anticoagulant. Phenotyping
of red cell antigens were performed immediately after the blood collection. Every
day, ten donor samples were typed and every tenth donor sample was included in
the study. 
Clinically significant blood antigens of the ABO,
Rh (D, C, c, E, and e), Kell, Duffy and Kidd blood group systems were studied. The
ABO and Rh(D) grouping were performed by tube technique using monoclonal
antisera (Tulip Diagnostics, India). The blood units tested positive for Rh(D)
antigen were labelled as Rh(D) positive. The Rh(D) negative units were further
tested for the presence of weak D by column agglutination technique, using IgG
monoclonal antisera anti-D (Tulip Diagnostics, Goa, India). All blood samples
were phenotyped for Rh(C, c, E, e), Kell, Duffy and Kidd antigens using column
agglutination technique. The phenotyping was done using the ID-Diaclon gel
cards (Bio-Rad, Cressier, Switzerland). A 0.8% low-ionic strength solution was
used for the preparation of red cell suspension. One positive and one negative
control for each antigen were selected from the commercial cell panels (DiaCell
and DiaPanel, Bio-Rad, Cressier, Switzerland). The column agglutination test
for antigen phenotyping was performed as per the manufacturer&#039;s instructions.
The test results thus derived using the CAT were graded from negative to 4+
reaction.
&amp;nbsp;
Results
Blood samples from 200 donors were typed for ABO,
Rh (D, C, c, E and e), Kell, Duffy and Kidd antigens. The distribution of ABO and
Rh blood groups is shown in Table-1. The most common group was found to be O
(38%), followed by A (31%), B (26%), and AB (5%). Of these, 184 (92%) donors
were Rh(D) positive and the remaining 16 (8%) donors were Rh(D) negative. Among
the Rh antigens, the e antigen was found to be the most prevalent with a
frequency of 97.8% and 100% among the Rh(D) positive and Rh(D) negative donors respectively
(Table-2). The C antigen was found more frequently in Rh(D) positive donors
compared to Rh(D) negative donors (90.8% vs. 6.3%, respectively). The c antigen
was expressed by 100% of D negative donors, while only 40.76 % D positive
donors expressed the c antigen. The E antigen was found in 19% RhD positive donors.

&amp;nbsp;
Table-1: Distribution of ABO and Rh
blood groups of the study population (N=200)
&amp;nbsp;
&amp;nbsp;
Table-2: Prevalence of Rh antigens
among RhD positive and negative donors 
&amp;nbsp;
&amp;nbsp;
Table-3 depicts the phenotype frequencies of
Rh-positive and Rh-negative groups. A total of 6 and 2 Rh phenotypes were
observed among the Rh(D) positive and negative donors respectively. Among Rh
positive group, R1R1 phenotype was the most frequent (47.3%), followed by the
R1r (31.5%) and R1R2 (11%). Among the Rh(D) negative donors, the Rr phenotype
was observed to be the most frequent (93.7%), followed by the r&#039;r (6.3%).
&amp;nbsp;
Table-3: Phenotype distribution of Rh-positive
(n =184) and Rh-negative groups (n=16)
&amp;nbsp;
&amp;nbsp;
Table-4 enumerates the prevalence of other
minor antigens. In the Kell blood group system, the K and Kpa antigens
were absent in all donors. The k (Cellano) and Kpb antigens were
found in 100% of our donors. In the Duffy blood group system, Fya
and Fyb antigens were expressed by 89% and 57.5% of the donors
respectively. In the Kidd blood group system, the Jka antigen was
found in 87% of the donors, while 62% of the donors expressed the Jkb
antigen on their red cells. Detail Kell, Duffy and Kidd phenotype frequencies
among the donors is illustrated in Table-5.
&amp;nbsp;
Table-4: Prevalence of other red
cell antigens among the study population (N=200)
&amp;nbsp;
&amp;nbsp;
Table-5: Distribution of Kell,
Duffy and Kidd phenotypes in study population (N=200).
&amp;nbsp;
&amp;nbsp;
Discussion
Antibodies to ABO, Rh and other clinically
significant antigens are known to cause hemolytic transfusion reaction, hemolytic
disease of the fetus and newborn (HDFN), or shortened survival of transfused
red cells [4]. Thorough knowledge of these clinically significant antigens can
help in prevention of allo-immunization in chronic multi-transfused patients.
The prevalence study of such antigens is available for Caucasians and Black
races [5-7], whereas only limited information is there regarding the prevalence
of these antigens in Indian population.
In the present study, the ABO blood group
antigen frequencies showed the prevalence as O &amp;gt; B &amp;gt; A &amp;gt; AB which was similar
to other studies from South India [8,9] but in contrast to some Indian studies
where B blood group was reported more prevalent [10,11]. It is due to the multiethnic
population of our country and as a result studies in different region of India
reported varied prevalence of ABO blood group. In India, the frequency of D negative
antigen varies from 5% to 10% [8-12]. The frequency of Rh(D) positive in our study
was 92%, whereas only 8% were Rh(D) negative. The e, D and C antigens were
found to have the highest frequency. The C antigen was found to be more
associated with presence of D antigen (90.8%). The R1R1 phenotype was the most
frequent among Rh(D) positive donors and Rr among the Rh(D) negative donors. This
is similar to other studies from India [9-14].
The K antigen was not detected in any of our donor
samples. The prevalence has been shown to vary among different Indian
populations. One study from India reported a low K antigen prevalence of only
0.79% [15]. The K-k+ was certainly the most common phenotype observed in our
donor population.
In the Kidd blood group system, Jk(a+b+) was the
most common phenotype, accounting for 49%. No Jk (a-b-) phenotype was observed.
This was similar to studies by Makroo et al in which the sample size was much
higher than our study [12]. Regarding the Duffy blood group system, the results
observed were similar to other studies from the country. The null phenotype
Fy(a-b-) was not detected, which was similar to other Indian studies but
contrary to a study conducted in Western India, which demonstrated Fy(a-b-) as
the most prevalent (48.7%) phenotype [16].
The finding of red cell antigen prevalence in
our study is beneficial in providing appropriate immunohematology laboratory
services with limited resources. A cost-effective in-house antibody screening
panel of cells can be developed based on the regional antigen prevalence. The
data can be used for finding the number of units to be cross matched to find a
compatible unit in allosensitized multi-transfused patients. A rare donor
registry can be developed and if introduced would be helpful to the entire
nation in future.
&amp;nbsp;
Acknowledgment

As the extended phenotyping for antigens is
not performed routinely in our Blood bank, the authors thank State Board of
Medical Research for funding this study. 
&amp;nbsp;
Conflict
of interest
The authors declare no conflict of interest.
&amp;nbsp;
Fund
The study was funded by State Board of Medical
Research. 
&amp;nbsp;
References
1.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Sinha S, Seth T, Colah
RB, Bittles AH. Haemoglobinopathies in India: estimates of blood requirements
and treatment costs for the decade 2017-2026. J Community Genet. 2020 Jan; 11(1):
39-45. doi: 10.1007/s12687-019-00410-1. 
2.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Matteocci A, Pierelli
L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia:
current status, future perspectives and potential role of molecular typing. Vox Sang. 2014 Apr; 106(3): 197-208. doi: 10.1111/vox.12086. 
3.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; ISBT
Terminology Committee. Red Cell
Immunogenetics and Blood Group Terminology. International Society of Blood
Transfusion. 2023. Archived from the original on 7 October 2022. Available from
http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/
4.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Poole J, Daniels G.
Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007; 21(1): 58-71. doi:
10.1016/j.tmrv.2006.08.003. 
5.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Brecher ME. Technical manual,
American Association of Blood Banks, Bethesda, Md, USA, 15th edition, 2005.
6.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Daniels G. Human blood
groups, Blackwell Science, Oxford, UK, 2nd edition, 2002. doi:10.1002/9780470987018
7.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Harmening D. Modern blood
banking and transfusion practices, FA Davis Company, Philadelphia, PA, USA, 5th
edition, 2005.
8.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; John S. Prevalence of
ABO and rhesus blood groups in blood donors: a study from a tertiary care
centre in South Kerala. Int J Contemp Med Res. 2017; 4(11): 2314-2316.
9.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Subramaniyan R.
Phenotyping of clinically significant blood group antigens among the South
Indian donor population. Hematol Transfus
Cell Ther. 2023; 45 Suppl
2(Suppl 2): S30-S35. doi: 10.1016/j.htct.2021.11.012.
10.&amp;nbsp; Prinja N, Narain R. ABO,
Rh, and kell blood group antigen frequencies in blood donors at the tertiary
care hospital of Northwestern India. Asian
J Transfus Sci. 2020; 14: 179-84.
doi: 10.4103/ajts.AJTS_34_19.
11.&amp;nbsp; Agarwal N, Thapliyal RM,
Chatterjee K. Blood group phenotype frequencies in blood donors from a tertiary
care hospital in north India. Blood Res.
2013; 48: 51‑54. doi:
10.5045/br.2013.48.1.51.
12.&amp;nbsp; Makroo RN, Bhatia A,
Gupta R, Phillip J. Prevalence of Rh, Duffy, Kell, Kidd &amp;amp; MNSs blood group
antigens in the Indian blood donor population. Indian J Med Res. 2013; 137(3):
521-526.
13.&amp;nbsp; Setya
D, Tiwari AK, Arora D, Mitra S, Mehta SP, Aggarwal G.
The frequent and the unusual red cell phenotypes in Indian blood donors: a quest
for rare donors. Transfus Apher Sci.
2020; 59(4): 102765. doi:
10.1016/j.transci.2020.102765.
&amp;nbsp;14. Nanu A, Thapliyal RM. Blood group gene frequency in a selected north
Indian population. Indian J Med Res. 1997;
106: 242–246.
15.&amp;nbsp; Basu D, Datta SS,
Montemayor C, Bhattacharya P, Mukherjee K, Flegel WA. ABO, Rhesus, and Kell antigens,
alleles, and haplotypes in West Bengal, India. Transfus Med Hemother. 2018; 45(1):
62-66. doi: 10.1159/000475507.
16.&amp;nbsp; Kahar
MA, Patel RD. Phenotype frequencies of blood group systems (Rh, Kell, Kidd,
Duffy, MNS, P, Lewis, and Lutheran) in blood donors of south Gujarat, India. Asian J Transfus Sci. 2014; 8: 51–55. doi:
10.4103/0973-6247.126693.
&amp;nbsp;
&amp;nbsp;
&amp;nbsp;
Cite this article as:
John S,
Achankunju AK, Suma MS, Nadanganan S. Clinically significant minor blood group
antigens amongst South Indian donor population. IMC J Med Sci. 2024; 18(1):004.
DOI: https://doi.org/10.55010/imcjms.18.004</description>

            </item>
            
    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>
</channel>
</rss>
